IL116405A - Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses - Google Patents

Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses

Info

Publication number
IL116405A
IL116405A IL11640595A IL11640595A IL116405A IL 116405 A IL116405 A IL 116405A IL 11640595 A IL11640595 A IL 11640595A IL 11640595 A IL11640595 A IL 11640595A IL 116405 A IL116405 A IL 116405A
Authority
IL
Israel
Prior art keywords
methoxy
dione
hexahydro
benz
ethyl
Prior art date
Application number
IL11640595A
Other languages
English (en)
Hebrew (he)
Other versions
IL116405A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL116405A0 publication Critical patent/IL116405A0/xx
Publication of IL116405A publication Critical patent/IL116405A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11640595A 1995-01-27 1995-12-15 Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses IL116405A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37941495A 1995-01-27 1995-01-27
US08/463,528 US5597823A (en) 1995-01-27 1995-06-05 Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists

Publications (2)

Publication Number Publication Date
IL116405A0 IL116405A0 (en) 1996-03-31
IL116405A true IL116405A (en) 2001-09-13

Family

ID=27008615

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11640595A IL116405A (en) 1995-01-27 1995-12-15 Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses

Country Status (15)

Country Link
US (1) US5597823A (de)
EP (1) EP0808318B1 (de)
JP (1) JP2001504797A (de)
KR (1) KR19980701700A (de)
AT (1) ATE194141T1 (de)
AU (1) AU705283B2 (de)
CA (1) CA2211212A1 (de)
DE (1) DE69609051T2 (de)
DK (1) DK0808318T3 (de)
ES (1) ES2149451T3 (de)
GR (1) GR3034485T3 (de)
IL (1) IL116405A (de)
MX (1) MX9705674A (de)
PT (1) PT808318E (de)
WO (1) WO1996022992A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
AR008395A1 (es) * 1996-07-09 2000-01-19 Astra Pharma Prod Compuesto derivado de pirimidina, composicion farmaceutica que lo comprende, procedimiento para prepararlo, y compuesto intermediario util parallevar a cabo dicho procedimiento.
US5891882A (en) * 1996-12-06 1999-04-06 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
WO1998057638A1 (en) * 1997-06-18 1998-12-23 Merck & Co., Inc. ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
WO1999048530A1 (en) * 1998-03-23 1999-09-30 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6133275A (en) * 1998-05-06 2000-10-17 Abbott Laboratories 3-phenylpyrrolidine alpha-1 adrenergic compounds
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CZ301763B6 (cs) 1998-08-20 2010-06-16 Toyama Chemical Co., Ltd. Protivirový prostredek a derivát dusíkatého heterocyklického karboxamidu
JP2002523405A (ja) * 1998-08-20 2002-07-30 アボット・ラボラトリーズ レジオ選択的置換ピラジン異性体を製造するための方法
EE200100341A (et) * 1998-12-24 2002-12-16 Aventis Pharmaceuticals Products Inc. Asendatud (aminoiminometüül- või aminometüül)bensoheteroarüülühendid, nende kasutamine ja farmatseutiline kompositsioon
US6867203B2 (en) 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
JP2005104838A (ja) 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
US7754709B2 (en) * 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US7524853B2 (en) * 2003-06-10 2009-04-28 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7465739B2 (en) * 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US20070045902A1 (en) 2004-07-13 2007-03-01 Brauker James H Analyte sensor
US8170803B2 (en) 2004-07-13 2012-05-01 Dexcom, Inc. Transcutaneous analyte sensor
DE602004021145D1 (de) * 2004-12-13 2009-06-25 Solvay Pharm Gmbh NEUE SUBSTITUIERTE THIOPHENPYRIMIDINONDERIVATE ALS INHIBITOREN VON 17ß-HYDROXYSTEROIDDEHYDROGENASE
EP1888548B1 (de) 2005-05-26 2012-08-22 Neuron Systems, Inc Chinolinderivat zur Behandlung von Netzhauterkrankungen
BRPI0611993B1 (pt) 2005-06-23 2023-11-28 Array Biopharma, Inc. Compostos de benzimidazol e seu processo de preparação
CA2627349A1 (en) * 2005-11-03 2007-05-18 Ilypsa, Inc. Azaindole compounds and use thereof as phospholipase-a2 inhibitors
JP5041403B2 (ja) * 2007-02-02 2012-10-03 国立大学法人北海道大学 カフェイン類縁体
JP5885670B2 (ja) 2009-12-11 2016-03-15 アルデイラ セラピューティクス, インコーポレイテッド 黄斑変性の処置のための組成物および方法
KR20150118106A (ko) 2012-12-20 2015-10-21 알데이라 테라퓨틱스, 아이엔씨. 페리-카르비놀
EP2948149A4 (de) 2013-01-23 2016-12-14 Aldeyra Therapeutics Inc Durch toxisches aldehyd bedingte erkrankungen und behandlung
CN105228989A (zh) 2013-01-25 2016-01-06 奥尔德拉医疗公司 黄斑变性治疗中的新颖捕获剂
KR102664994B1 (ko) 2015-08-21 2024-05-13 알데이라 테라퓨틱스, 아이엔씨. 중수소화 화합물 및 이의 용도
CN109152774A (zh) 2016-05-09 2019-01-04 奥尔德拉医疗公司 眼部炎性病症和疾病的组合治疗
JP2020511461A (ja) 2017-03-16 2020-04-16 アルデイラ セラピューティクス, インコーポレイテッド 多形化合物およびその使用
MX2020003425A (es) 2017-10-10 2020-07-29 Aldeyra Therapeutics Inc Tratamiento de trastornos inflamatorios.
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CN112079832A (zh) * 2020-10-30 2020-12-15 黑龙江中医药大学 一种治疗子宫肌瘤的药物及其制备方法
CN114957090B (zh) * 2021-12-31 2023-09-19 淮阴师范学院 稠合异吲哚衍生物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
GB9123857D0 (en) * 1991-11-09 1992-01-02 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP0808318B1 (de) 2000-06-28
KR19980701700A (ko) 1998-06-25
GR3034485T3 (en) 2000-12-29
EP0808318A1 (de) 1997-11-26
AU705283B2 (en) 1999-05-20
PT808318E (pt) 2000-12-29
JP2001504797A (ja) 2001-04-10
DE69609051T2 (de) 2001-03-22
AU4745796A (en) 1996-08-14
ES2149451T3 (es) 2000-11-01
DE69609051D1 (de) 2000-08-03
CA2211212A1 (en) 1996-08-01
MX9705674A (es) 1997-10-31
WO1996022992A1 (en) 1996-08-01
US5597823A (en) 1997-01-28
IL116405A0 (en) 1996-03-31
DK0808318T3 (da) 2000-10-16
ATE194141T1 (de) 2000-07-15

Similar Documents

Publication Publication Date Title
EP0808318B1 (de) Tricyclische substituierte hexahydrobenz[e]isoindol alpha-1-adrenergische antagonisten
AU694611B2 (en) Bicyclic substituted hexahydrobenz{e}isoindole alpha-1- adrenergic antagonists
AU2015238541B2 (en) Condensed [1,4]diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
KR101586870B1 (ko) (디히드로)피롤로[2,1-a]이소퀴놀린
AU626452B2 (en) Condensed diazepinones
PH12015500263B1 (en) New bicyclic derivatives
US5891882A (en) Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
JP2019519582A (ja) ベンゾジオキサン誘導体およびその医薬用途
US5521181A (en) Bicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonists
EP0942911B1 (de) Benzopyranopyrrole und benzopyranopyridine mit alpha-1 adrenergische wirkung
MX2012012279A (es) Moduladores de los receptores 5-ht y metodos de uso de los mismos.
IE851712L (en) Pyrazolopyridines
IE903279A1 (en) Condensed diazepinones
Esser et al. Cyclic Guanidines; III1 Synthesis of Novel 8, 13, 15-Triazasteroids and Related Heterocycles

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees